{"id":75373,"date":"2023-09-07T10:39:35","date_gmt":"2023-09-07T05:09:35","guid":{"rendered":"http:\/\/finservwealth.com\/sme-mono-pharmacare-has-tepid-start-lists-at-4-premium-to-issue-price\/"},"modified":"2023-09-07T10:39:35","modified_gmt":"2023-09-07T05:09:35","slug":"sme-mono-pharmacare-has-tepid-start-lists-at-4-premium-to-issue-price","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/sme-mono-pharmacare-has-tepid-start-lists-at-4-premium-to-issue-price\/","title":{"rendered":"SME Mono Pharmacare has tepid start, lists at 4% premium to issue price"},"content":{"rendered":"<p> The company, which is concentrated in western  Gujarat, works with various contract manufacturers, who make pharmaceutical products based on compositions given by the company, and sells them under the brand DLS Export<\/p><div id=\"finse-3405308025\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/sme\/sme-mono-pharmacare-has-tepid-start-lists-at-4-premium-to-issue-price_17231671.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The company, which is concentrated in western  Gujarat, works with various contract manufacturers, who make pharmaceutical products based on compositions given by the company, and sells them under the brand DLS Export The company, which is concentrated in western  Gujarat, works with various contract manufacturers, who make pharmaceutical products based on compositions given by the company, and sells them under the brand DLS Export\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/sme\/sme-mono-pharmacare-has-tepid-start-lists-at-4-premium-to-issue-price_17231671.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> The company, which is concentrated in western  Gujarat, works with various contract manufacturers, who make pharmaceutical products based on compositions given by the company, and sells them under the brand DLS Export<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/sme\/sme-mono-pharmacare-has-tepid-start-lists-at-4-premium-to-issue-price_17231671.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0The company, which is concentrated in western  Gujarat, works with various contract manufacturers, who make pharmaceutical products based on compositions given by the company, and sells them under the brand DLS Export The company, which is concentrated in western  Gujarat, works with various contract manufacturers, who make pharmaceutical products based on compositions given by the company, and sells them under the brand DLS Export\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/sme\/sme-mono-pharmacare-has-tepid-start-lists-at-4-premium-to-issue-price_17231671.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> The company, which is concentrated in western  Gujarat, works with various contract manufacturers, who make pharmaceutical products based on compositions given by the company, and sells them under the brand DLS Export<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-75373","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2023\/200x200\/p\/pharma_tablet_injection_capsule_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/75373","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=75373"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/75373\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=75373"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=75373"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=75373"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}